Tango Therapeutics
The Director, GCP & GLP QA leads quality assurance oversight across clinical and nonclinical programs, ensuring compliance with GCP, GLP, and global regulatory requirements. This role manages audit strategy, vendor and CRO quality, inspection readiness, and quality events, while providing strategic QA guidance to internal teams and external partners.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2017
Tango Therapeutics is a precision oncology company that discovers and develops targeted cancer therapies by exploiting tumor-selective genetic vulnerabilities, especially via synthetic lethality approaches. The company combines functional genomics, computational biology, and a proprietary target-discovery platform to identify novel cancer targets and advance programs from discovery into the clinic. Tango focuses on genetically defined patient populations and partners with pharma to translate its discoveries into therapeutic candidates with the goal of delivering more effective, less toxic treatments.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Tango Therapeutics.
10% above the average for this role
Tango Therapeutics’ (TNGX) Sees Cautious Analyst Optimism Following Earnings
3 days ago
Associate Director, GCP QA
Mirum Pharmaceuticals
Associate Director Early Development Quality Lead R D Qa United States
alnylam
Associate Director, GLP/GCP Quality Audits and Compliance
Acadia Pharmaceuticals Inc.
GLP/GCP Toxicology Quality Assurance Auditor
Labcorp
Director, Global GCP QA
Structure Therapeutics
Director, Global Quality Assurance, GCP/GLP
Zenas BioPharma